0001183740-18-000095.txt : 20180517 0001183740-18-000095.hdr.sgml : 20180517 20180517132049 ACCESSION NUMBER: 0001183740-18-000095 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180517 EFFECTIVENESS DATE: 20180517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iANTHUS CAPITAL HOLDINGS, INC. CENTRAL INDEX KEY: 0001643154 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-305916 FILM NUMBER: 18842429 BUSINESS ADDRESS: STREET 1: SUITE 1980, 1075 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6E 3C9 BUSINESS PHONE: 604-688-9588 MAIL ADDRESS: STREET 1: SUITE 1980, 1075 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6E 3C9 FORMER COMPANY: FORMER CONFORMED NAME: GENARCA HOLDINGS LTD DATE OF NAME CHANGE: 20150522 D/A 1 primary_doc.xml X0708 D/A LIVE 0001643154 iANTHUS CAPITAL HOLDINGS, INC. SUITE 1980, 1075 WEST GEORGIA ST. VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 3C9 604-688-9588 BRITISH COLUMBIA, CANADA GENARCA HOLDINGS LTD Corporation true 2013 Julius Kalcevich Suite 414, 420 Lexington Avenue New York NY NEW YORK 10170 Executive Officer Director Hadley Ford Suite 414, 420 Lexington Avenue New York NY NEW YORK 10170 Executive Officer Director Randy Maslow Suite 414, 420 Lexington Avenue New York NY NEW YORK 10170 Executive Officer Director John Henderson Suite 414, 420 Lexington Avenue New York NY NEW YORK 10170 Executive Officer Director Richard Boxer Suite 414, 420 Lexington Avenue New York NY NEW YORK 10170 Director Paul Rosen Suite 414, 420 Lexington Avenue New York NY NEW YORK 10170 Director Other Decline to Disclose 06b true 0001183740-18-000041 2018-02-01 false true true Common Shares and Class A convertible restricted shares at $2.57 per share were issued in connection with the Issuer's acquisition of Citiva Medical, LLC and Citiva, LLC, by way of merger using its wholly-owned subsidiary, iAnthus Holdings New York, LLC. 0 12457463 12457463 0 Total Offering Amount represents the aggregate deemed price of 2,869,699 Common Shares & 1,977,563 Class A convertible restricted shares at $2.57 per share, issued in connection with the Issuer's acquisition of Citiva Medical, LLC and Citiva, LLC. false 54 0 0 0 false iANTHUS CAPITAL HOLDINGS, INC. /s/ Julius Kalcevich Julius Kalcevich Chief Financial Officer 2018-05-17